Fifth Third already beats its 2027 return target with conversion done and costs still falling. I see $5.20 of 2027 profit worth 11 times, or $57.20, for 13% upside plus a 3.3% yield.
Key points
- $1.50 billion of adjusted pre-provision profit (profit before loan-loss reserves) grew 8% sequentially.
- 20.6% adjusted return on tangible equity (profit on real net worth) already beats the 19% 2027 deal target.
- $200 to $300 million of fourth-quarter buybacks restart capital return after a September pause.
The call
The market is too pessimistic about synergy follow-through. At $50.56 and 11 times profit, the price requires only $4.60 of 2027 profit per share. That is barely above a $4.25 annualized 2026 run rate.
FTE revenue jumps with Comerica, then growsCompany releases; Q4 FY26E is mine. FTE revenue, non-GAAP.
I see faster profit instead from a full synergy quarter. Fourth-quarter revenue near $3.43 billion and costs near $1.77 billion support $1.26 per share. That path plus loan growth and buybacks drives $5.20 in 2027.
Adjusted profit climbs as synergies landCompany releases; Q4 FY26E is mine. Adjusted EPS, dollars per share.
Valuation
| Measure | Figure |
|---|
| Q4 2026 adjusted EPS, mine | $1.26 |
| 2027 EPS, mine | $5.20 |
| Target multiple | 11 times |
| Dividend, annualized | $1.68 a share |
| Target | $57.20 a share |
Peers trade near 11 to 13 times past profit. A 20.6% return on tangible equity supports 11 times forward profit here. Upside of 13% plus a 3.3% yield makes risk and reward favorable for a buy.
Risks
- Deposit costs keep rising and offset rate gains, which you would see in a falling 3.34% margin.
- Acquired deposits leave after conversion, which you would see in lower core deposits and higher wholesale funding.
- Credit slips in rate-sensitive loans, which you would see in charge-offs above 35 basis points.
What would change my mind
I would turn cautious if fourth-quarter costs fail to fall 2 to 3% sequentially despite completed conversion.